Zeidan, A. M. (2018). Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation. American Society of Hematology (ASH).
Chicago Style (17th ed.) CitationZeidan, A. M. Long-term Survival of Older Patients with MDS Treated with HMA Therapy Without Subsequent Stem Cell Transplantation. American Society of Hematology (ASH), 2018.
MLA (9th ed.) CitationZeidan, A. M. Long-term Survival of Older Patients with MDS Treated with HMA Therapy Without Subsequent Stem Cell Transplantation. American Society of Hematology (ASH), 2018.
Warning: These citations may not always be 100% accurate.